Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Sep 7, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | A | A | $688.27B | 946,456,759 | 83.71% | 10.91% | Net Selling | Net Selling |
| RYAAY | RYANAIR HOLDINGS PLC | A | B | $32.19B | 1,063,868,001 | 20.65% | 0.00% | ||
| WIX | WIXCOM LTD | A | B | $8.56B | 55,905,451 | 87.43% | 0.00% | ||
| BGC | BGC GROUP INC | A | C | $4.71B | 474,315,045 | 38.33% | 61.67% | Net Selling | Net Selling |
| IHS | IHS HOLDING LTD | A | B | $2.44B | 335,521,000 | 37.71% | 0.00% | ||
| DBD | DIEBOLD NIXDORF INC | A | B | $2.19B | 36,633,544 | 82.99% | 17.01% | Net Selling | |
| FIVN | FIVE9 INC | A | B | $2.06B | 77,262,690 | 71.90% | 28.10% | Net Selling | Net Selling |
| ARDT | ARDENT HEALTH PARTNERS INC | A | A | $1.88B | 143,106,447 | 46.26% | 53.74% | Net Selling | |
| NTCT | NETSCOUT SYSTEMS INC | A | B | $1.77B | 71,328,733 | 77.64% | 22.36% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | C | $1.74B | 209,920,430 | 84.08% | 15.92% | Net Selling | Net Buying |
| AVDL | AVADEL PHARMACEUTICALS PLC | A | B | $1.53B | 97,097,639 | 83.77% | 13.63% | Net Buying | |
| GBX | GREENBRIER COMPANIES INC | A | B | $1.46B | 30,883,672 | 88.64% | 11.36% | Net Selling | Net Selling |
| DCO | DUCOMMUN INC | A | C | $1.35B | 14,877,749 | 88.44% | 10.45% | Net Selling | Net Selling |
| LMB | LIMBACH HOLDINGS INC | A | B | $1.25B | 11,626,814 | 40.83% | 59.17% | Net Selling | Net Selling |
| EVER | EVERQUOTE INC | A | B | $859.51M | 36,512,857 | 59.09% | 40.91% | Net Selling | Net Selling |
| NRDS | NERDWALLET INC | A | B | $795.79M | 74,512,609 | 36.70% | 47.29% | Net Selling | Net Selling |
| AKBA | AKEBIA THERAPEUTICS INC | A | B | $777.40M | 262,635,836 | 41.23% | 7.72% | Net Selling | Net Selling |
| TBPH | THERAVANCE BIOPHARMA INC | A | B | $702.54M | 50,361,296 | 51.78% | 48.22% | Net Selling | Net Selling |
| KMDA | KAMADA LTD | A | A | $410.59M | 57,505,031 | 10.05% | 0.00% | ||
| ELMD | ELECTROMED INC | A | B | $204.30M | 8,349,176 | 30.68% | 69.32% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.